Literature DB >> 16129655

Conservative parotidectomy for the treatment of parotid cancers.

Young Chang Lim1, Sei Young Lee, Kyubo Kim, Jin Seok Lee, Bon Seok Koo, Hyang Ae Shin, Eun Chang Choi.   

Abstract

A conservative parotidectomy is defined as any procedure that is less than a classic superficial parotidectomy, and where less than a full facial nerve is dissected. The aim of this study was to evaluate the oncologic effects of a conservative parotidectomy in a series of patients with malignant tumors of the parotid gland. The medical records of 43 patients treated at Severance Hospital from 1992 to 2002 who had been diagnosed with parotid cancers confined to the superficial lobe, and had also undergone conservative parotidectomies were reviewed. There were 16 males and 27 females, ranging in age from 8 to 84 years. Sixteen tumors (37%) were high-grade and 27 tumors (63%) were low-grade cancers. Twenty-four patients underwent neck dissection simultaneously with the primary lesion. Surgical treatment was followed by radiotherapy in 10 patients. The follow-up period ranged from 8 to 130 months, with a mean duration of time at 57.7 months. The overall survival rate and the disease-free rate at five years were 88% and 79%, respectively. Univariate analyses showed histologic tumor grade (p = 0.003) and pathologic neck node metastasis (p < 0.001) to be significant variables. Based on multivariate analysis, only the presence of pathologically positive lymph nodes proved to be significant (p = 0.001). Occult metastases rates was 25% (3 of 12 cases) for high-grade tumors and none of the low-grade tumors had microscopic metastases. Recurrences developed in eight cases (19%). Four cases (9%) had a local or locoregional failure. Of these cases, two cases were high-grade tumors (13%, 2 of 16) and the other two cases were low-grade tumors (7%, 2 of 27). The six cases (14%) of which four cases were high-grade (25%) and two cases were low-grade (7%) had positive surgical margin but showed no evidence of local recurrence after additional postoperative radiotherapy. The incidence of postoperative facial nerve paralysis (HB > 1) was 12% (5 out of 43) for a temporary deficit, but there was no permanent paralysis. Conservative parotidectomy with appropriate postoperative radiotherapy may be an acceptable procedure without potential morbidity, such as postoperative facial palsy, in the treatment of low-grade parotid cancers confined to the superficial lobe if the facial nerve is sufficiently distant from the tumor.

Entities:  

Mesh:

Year:  2005        PMID: 16129655     DOI: 10.1016/j.oraloncology.2005.06.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Management of malignant parotid tumors.

Authors:  Nikolaos Papadogeorgakis; Lampros Goutzanis; Vassilis Petsinis; Constantinos Alexandridis
Journal:  Oral Maxillofac Surg       Date:  2011-01-05

Review 2.  Parotidectomy for Parotid Cancer.

Authors:  Jennifer R Cracchiolo; Ashok R Shaha
Journal:  Otolaryngol Clin North Am       Date:  2016-02-17       Impact factor: 3.346

Review 3.  [Surgery for parotid gland cancer-controversial and proven aspects].

Authors:  Konstantinos Mantsopoulos; Heinrich Iro
Journal:  HNO       Date:  2022-05-17       Impact factor: 1.284

Review 4.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

5.  Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Authors:  Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin
Journal:  Cancer Cytopathol       Date:  2020-04-08       Impact factor: 5.284

Review 6.  Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy.

Authors:  Young Min Park; Yoon Woo Koh
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

Review 7.  AlloDerm implants for prevention of Frey syndrome after parotidectomy: a systematic review and meta-analysis.

Authors:  Xian-Tao Zeng; Xiang-Jun Tang; Xue-Jun Wang; Miao-Zhu Li; Yi Guo; Wei Huang; Yu-Ming Niu; Wei-Dong Leng
Journal:  Mol Med Rep       Date:  2012-01-20       Impact factor: 2.952

8.  Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors.

Authors:  Gang Huang; Guangqi Yan; Xinli Wei; Xin He
Journal:  Oncol Lett       Date:  2014-11-27       Impact factor: 2.967

9.  Correlations between the clinical, histological and neurophysiological examinations in patients before and after parotid gland tumor surgery: verification of facial nerve transmission.

Authors:  Agnieszka Wiertel-Krawczuk; Juliusz Huber; Magdalena Wojtysiak; Wojciech Golusiński; Piotr Pieńkowski; Paweł Golusiński
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-17       Impact factor: 2.503

10.  Deep Learning for Differentiating Benign From Malignant Parotid Lesions on MR Images.

Authors:  Xianwu Xia; Bin Feng; Jiazhou Wang; Qianjin Hua; Yide Yang; Liang Sheng; Yonghua Mou; Weigang Hu
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.